Trust CO Pfizer Inc Transaction History

Trust CO

$1.03 Billion
Q4 2025

A detailed history of Trust CO transactions in Pfizer Inc stock. As of the latest transaction made, Trust CO holds 55,423 shares of PFE stock, worth $1.39 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

55,423

Previous 50,394 9.98%

Holding current value

$1.39 Million

Previous $1.28 Million 8.26%

% of portfolio

0.13%

Previous 0.14%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 15, 2026	BUY	$24.23 - $27.37 $121,852 - $137,643	5,029 Added 9.98%	55,423 $1.39 Million
Q3 2025 Oct 06, 2025	BUY	$23.29 - $25.88 $548,246 - $609,215	23,540 Added 87.66%	50,394 $1.28 Million
Q2 2025 Jul 07, 2025	BUY	$21.59 - $24.84 $483,292 - $556,043	22,385 Added 500.9%	26,854 $650,000
Q1 2025 Apr 08, 2025	BUY	$25.01 - $27.13 $20,733 - $22,490	829 Added 22.77%	4,469 $113,000
Q4 2024 Jan 14, 2025	BUY	$24.8 - $30.19 $4,960 - $6,038	200 Added 5.81%	3,640 $96,000

Q3 2024 Oct 03, 2024	SELL	$27.7 - $31.39 $9,611 - $10,892	-347 Reduced 9.16%	3,440 $99,000
Q2 2024 Jul 15, 2024	SELL	$25.26 - $29.6 $8,714 - $10,212	-345 Reduced 8.35%	3,787 $105,000
Q1 2024 Apr 11, 2024	SELL	$25.89 - $29.73 $9,242 - $10,613	-357 Reduced 7.95%	4,132 $114,000
Q4 2023 Jan 10, 2024	SELL	$26.13 - $33.94 $212,410 - $275,898	-8,129 Reduced 64.42%	4,489 $129,000
Q3 2023 Dec 04, 2023	SELL	$32.09 - $37.51 $42,230 - $49,363	-1,316 Reduced 9.44%	12,618 $418,000
Q2 2023 Jul 10, 2023	BUY	$36.12 - $41.79 $62,162 - $71,920	1,721 Added 14.09%	13,934 $511,000
Q1 2023 Apr 07, 2023	SELL	$39.39 - $51.28 $32,575 - $42,408	-827 Reduced 6.34%	12,213 $498,000
Q4 2022 Jan 09, 2023	BUY	$41.75 - $54.5 $208 - $272	5 Added 0.04%	13,040 $668,000
Q3 2022 Oct 11, 2022	SELL	$43.76 - $53.42 $108,656 - $132,641	-2,483 Reduced 16.0%	13,035 $570,000
Q2 2022 Jul 06, 2022	SELL	$46.53 - $55.17 $618,151 - $732,933	-13,285 Reduced 46.12%	15,518 $814,000
Q1 2022 Apr 08, 2022	BUY	$45.75 - $56.69 $691,923 - $857,379	15,124 Added 110.56%	28,803 $1.49 Million
Q4 2021 Jan 14, 2022	SELL	$41.32 - $61.25 $1,156 - $1,715	-28 Reduced 0.2%	13,679 $808,000
Q3 2021 Oct 20, 2021	SELL	$39.25 - $50.42 $452,591 - $581,393	-11,531 Reduced 45.69%	13,707 $590,000
Q2 2021 Jul 14, 2021	SELL	$35.91 - $40.68 $55,911 - $63,338	-1,557 Reduced 5.81%	25,238 $988,000
Q1 2021 Apr 08, 2021	BUY	$33.49 - $37.77 $686,109 - $773,793	20,487 Added 324.78%	26,795 $971,000
Q4 2020 Jan 12, 2021	BUY	$33.47 - $42.56 $40,666 - $51,710	1,215 Added 23.86%	6,308 $232,000
Q3 2020 Oct 06, 2020	BUY	$31.75 - $37.25 $46,228 - $54,236	1,456 Added 40.03%	5,093 $187,000
Q2 2020 Jul 17, 2020	SELL	$30.12 - $36.54 $35,270 - $42,788	-1,171 Reduced 24.36%	3,637 $119,000
Q1 2020 Apr 07, 2020	SELL	$27.03 - $38.62 $25,273 - $36,109	-935 Reduced 16.28%	4,808 $157,000
Q4 2019 Jan 07, 2020	SELL	$32.92 - $37.36 $288,905 - $327,871	-8,776 Reduced 60.44%	5,743 $225,000
Q3 2019 Oct 09, 2019	SELL	$32.49 - $42.13 $5,523 - $7,162	-170 Reduced 1.16%	14,519 $522,000
Q2 2019 Jul 08, 2019	SELL	$36.98 - $41.52 $2.87 Million - $3.22 Million	-77,567 Reduced 84.08%	14,689 $636,000
Q1 2019 Apr 08, 2019	SELL	$37.5 - $41.2 $382,575 - $420,322	-10,202 Reduced 9.96%	92,256 $3.92 Million
Q4 2018 Jan 22, 2019	BUY	$38.47 - $43.86 $3.5 Million - $4 Million	91,094 Added 801.6%	102,458 $4.47 Million
Q3 2018 Oct 09, 2018	SELL	$34.47 - $41.81 $6,583 - $7,985	-191 Reduced 1.65%	11,364 $501,000
Q2 2018 Jul 10, 2018	BUY	$32.98 - $35.16 $6,299 - $6,715	191 Added 1.68%	11,555 $419,000
Q3 2017 Oct 12, 2017	BUY	$31.0 - $34.15 $352,284 - $388,080	11,364	11,364 $406,000

Others Institutions Holding PFE

# of Institutions

3,372

Shares Held

3.57B

Call Options Held

86.1M

Put Options Held

105M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Trust CO with notifications on news.

Account